Muscle-specific Cand2 is translationally upregulated by mTORC1 and promotes adverse cardiac remodeling
Agnieszka Górska(Heidelberg University), Mirko Völkers(Heidelberg University), Christoph P. Hofmann(Heidelberg University), Verena Kamuf‐Schenk(Heidelberg University), Jennifer Furkel(Heidelberg University), Ellen Malovrh(Heidelberg University), Julie Ölschläger(Heidelberg University), Hugo A. Katus(Heidelberg University), Etienne Boileau(Heidelberg University), Mathias H. Konstandin(Heidelberg University), Shirin Doroudgar(University of Arizona), Claudia Stroh(Heidelberg University), Carsten Sticht(Heidelberg University), Vivien Kmietczyk(Heidelberg University), Eshita Varma(Heidelberg University), Christoph Dieterich(Heidelberg University), Clara Sandmann(Heidelberg University), Eva Riechert(Heidelberg University), Lonny Jürgensen(Heidelberg University), Norbert Frey(Heidelberg University)
Cited by 23
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k